HealthEquity

HealthEquity, Inc. provides range of solutions for managing health care accounts. The firm’s offers its solutions for employers, health plans, brokers, consultants and financial advisors. Its services include HAS, FSA, HRA, DCRA, 401(k), Commuter, COBRA and HIA. It also offers products like healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

HQY reports strong Q1 performance, faces challenges in seasonality and yield expectations

HQY's Q1 performance reflects strong growth and positive financial results, driven by increased HSA adoption and employer interest. However, the company faces challenges related to seasonality and yield expectations. To capitalize on opportunities, HQY should focus on reaching its enhanced rates target and addressing service fee pressures.

HealthEquity reports robust Q2 performance and eyes market expansion

HealthEquity's strong Q2 performance, driven by revenue and EBITDA growth, is supported by the enhanced rates product and expanded network partner footprint. While facing short-term challenges in interchange revenue and M&A environment changes, the company is well-positioned to capitalize on opportunities presented by market dynamics and regulatory discussions.

HealthEquity reports robust Q3 performance and optimistic fiscal '25 outlook

HealthEquity's Q3 performance showcased strong financial results, with raised fiscal '24 guidance and optimistic initial fiscal '25 guidance. The company is well-positioned to navigate challenges and capitalize on opportunities, particularly in expanding its market presence and enhancing customer satisfaction.

HealthEquity (HQY) posts record earnings, eyes growth through innovation

HealthEquity (HQY) delivered strong financial results, exceeding expectations and demonstrating growth across key metrics.
While facing challenges in certain business segments, the company's focus on technology, customer experience, and long-term quality positions it well for the future.
Opportunities for R&D acceleration, innovation through M&A, and expansion of product offerings present avenues for sustained growth and competitive advantage.

HealthEquity reports robust Q1 results, raises fiscal '24 guidance

HealthEquity's Q1 performance reflects strong financial growth and stability, with revenue, EBITDA, and HSA metrics showing positive trends.
The company's proactive approach to guidance revision, service fee optimization, and strategic partnerships positions it well for future success.
Challenges in managing fee pressures, COBRA impact, and M&A environment slowdown require focused strategies for sustained growth and market leadership.

HealthEquity reports robust Q2 results, eyes growth amid market shifts

HealthEquity's Q2 results reflect strong financial performance and strategic positioning for future growth.
Despite challenges in revenue consistency and market dynamics, the company's strengths in service quality and market leadership are key assets.
Opportunities in revenue growth, legislative changes, and market demand provide avenues for HealthEquity's continued success.

HealthEquity reports strong Q3 growth and bullish outlook for fiscal '25

HealthEquity's Q3 2024 earnings call highlighted impressive financial performance, strategic acquisitions, and optimistic guidance for fiscal '25, underlining the company's growth trajectory and market positioning.
While facing challenges in integrating acquisitions, maintaining competitive pricing, and managing asset maturation, HealthEquity remains focused on growth opportunities through enhanced yield products and consumer empowerment.
The company's emphasis on stability, profitability, and reinvestments, coupled with a proactive approach to engaging investors, sets the stage for continued success and market differentiation in the evolving healthcare landscape.

HealthEquity reports robust Q4 earnings, eyes growth through innovation

HealthEquity delivered strong financial results in Q4 2024, showcasing robust revenue growth and operational performance.
The company's focus on enhancing shareholder value, strategic mergers, and technology investments positions it well for future growth.
Challenges in pricing pressures and technology spend trends require careful navigation, while opportunities in HSA cash rates and digital innovations offer avenues for expansion.
Overall, HealthEquity's performance highlights resilience, strategic foresight, and a commitment to driving long-term value for stakeholders.

HealthEquity reports robust Q1 results, eyes cost savings and growth

HealthEquity's Q1 performance reflects strong growth in revenue, EBITDA, and HSA assets, underlining its market strength and operational efficiency.
The company's focus on cost savings, customer experience enhancement, and new sales growth positions it well for future success and market expansion.
While facing challenges in transitioning processes and managing costs, HealthEquity is leveraging opportunities in technology and market expansion to drive continued growth.

HealthEquity reports robust Q2 growth, unveils innovative healthcare payment options

HealthEquity's Q2 performance reflects strong growth and strategic initiatives to enhance healthcare payment options.
While facing challenges in margins and market conditions, the company's focus on innovation and team efforts bode well for future success.
Opportunities lie in leveraging HPAs, digital integration, and market expansion to drive continued growth and customer value.
Overall, HealthEquity's performance and outlook demonstrate resilience and a commitment to driving healthcare financial solutions.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

HealthEquity, Inc. engages in the provision of technology-enabled services for healthcare and spending decisions. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

We break down the key earnings takeaways for investors.

Here's How HealthEquity Performed During the COVID-19 Pandemic

DRAPER, Utah., Feb. 23, 2021 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent HSA custodian, today announced plans to release its fiscal year-end 2021 financial results following the close of regular stock market trading hours on Monday, March 15, 2021. Following the news release, HealthEquity management plans to host a conference call for investors on Monday, March 15, 2021, at 4:30 p.m. ET during which management will review highlights from the Company's fourth quarter and year-end results.

HealthEquity Sets Date to Announce Year-end Results

DRAPER, Utah, Feb. 19, 2021 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), today announced the closing of the underwritten public offering of 5,000,000 shares of its common stock. The gross proceeds to HealthEquity from the offering, before underwriting discounts and commissions, were $401,500,000. Additionally, HealthEquity has granted the underwriter a 30-day option to purchase up to an additional 750,000 shares. HealthEquity intends to use the net proceeds from this offering for potential acquisitions, repayment of indebtedness and other general corporate purposes.

HealthEquity Announces Closing of Follow-on Offering of Common Stock

DRAPER, Utah, Feb. 16, 2021 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), today announced the pricing of the previously announced underwritten public offering of 5 million shares of its common stock. BofA Securities may offer the shares of common stock from time to time to purchasers directly or through agents, or through brokers in brokerage transactions on the NASDAQ, or in the over-the-counter market, or to dealers in negotiated transactions or in a combination of such methods of sale, at a fixed price or prices, which may be changed, or at market prices prevailing at the time of sale, at prices related to such prevailing market prices or at negotiated prices. Gross proceeds to HealthEquity from the offering, before underwriting discounts and commissions, are expected to be $401.5 million. The offering is expected to close on February 19, 2021, subject to customary closing conditions. Additionally, HealthEquity has granted BofA Securities a 30-day option to purchase up to an additional 750,000 shares of its common stock. HealthEquity intends to use the net proceeds from this offering for potential acquisitions, repayment of indebtedness and other general corporate purposes.

HealthEquity Announces Pricing of Public Offering of Common Stock

DRAPER, Utah, Feb. 16, 2021 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), today announced that BofA Securities has agreed to purchase $400 million of shares of the Company's common stock. The underwriter may offer the shares of common stock from time to time to purchasers directly or through agents, or through brokers in brokerage transactions on the NASDAQ, or in the over-the-counter market, or to dealers in negotiated transactions or in a combination of such methods of sale, at a fixed price or prices, which may be changed, or at market prices prevailing at the time of sale, at prices related to such prevailing market prices or at negotiated prices. HealthEquity intends to use the net proceeds from this offering for potential acquisitions, repayment of indebtedness and other general corporate purposes.

HealthEquity Announces Commencement of Proposed Offering of Common Stock

HealthEquity: Continuing To Execute Well

On Monday, February 08, HealthEquity (NASDAQ:HQY) will report its last quarter's earnings. Here is Benzinga's preview of the company's release.

Earnings Outlook For HealthEquity

HealthEquity (HQY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why the Earnings Surprise Streak Could Continue for HealthEquity (HQY)

HealthEquity (HQY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HealthEquity (HQY) Expected to Beat Earnings Estimates: Should You Buy?

DRAPER, Utah, Jan. 25, 2021 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation's largest independent health savings account (“HSA") custodian, announced that it plans to release its fiscal year-end sales results following the close of regular stock market trading hours on Monday, February 8, 2021. Following the news release, HealthEquity management plans to host a conference call for investors on Monday, February 8, 2021 at 4:30 p.m. ET during which management will review January 31, 2021 year-end sales results.

HealthEquity Announces Date of Year-End Sales Conference Call, Presentation at Conferences

Centene

With the transition to the Biden administration, the policy footing for the future of healthcare is veering once again. But no matter how you slice it, the future is about more flexible care with a greater diversity of end-market options, and the decreasing viability of a one-size-fits-all solution to managing policies.

Radar: Disruptors in Health Benefits Stocks (NYSE: CNC) (OTC US: LVGI) (NASDAQ: HQY)

AMN Healthcare Services

AMN vs. HQY: Which Stock Is the Better Value Option?

AMN vs. HQY: Which Stock Should Value Investors Buy Now?

The HSA specialist's shares were swept higher with the overall stock market rise.

Why HealthEquity Stock Jumped Today

One of the largest providers of health savings accounts. Assets grow as individuals become more responsible for healthcare spending.

HealthEquity, Inc.: Antidote For Health Savings

HealthEquity (HQY) delivers strong growth in Service, Custodial and Interchange segments in Q3.

HealthEquity (HQY) Q3 Earnings and Revenues Beat Estimates

HealthEquity, Inc. (HQY) CEO Jon Kessler on Q3 2021 Results - Earnings Call Transcript

Coupa Software

Stitch Fix

Toll Brothers

These are the stocks posting the largest moves after the bell on Monday.

Stocks making the biggest moves after the bell: Stitch Fix, Coupa Software & more

HealthEquity Reports Third Quarter Ended October 31, 2020 Financial Results

While Fidelity is a leader in 401-k plans, HealthEquity has risen fast to become the leader in HSA plans, by number of accounts opened. It should benefit from the secular growth trend of the adult senior population, with healthcare spend being a top consideration.

HealthEquity: The Fidelity Of HSA Plans Is Growing Up Fast

On Monday, December 07, HealthEquity (NASDAQ:HQY) will release its latest earnings report. Here is Benzinga's outlook for the company.

HealthEquity's Earnings: A Preview

Includes 2021 tax changes and recent healthcare reform legislation Includes 2021 tax changes and recent healthcare reform legislation

14th edition of The Complete HSA Guidebook now available

DRAPER, Utah, Oct. 26, 2020 (GLOBE NEWSWIRE) -- HealthEquity, a leading administrator of health savings accounts (HSAs) and other consumer-directed benefits, is proud to announce two honors from technology platform ADP Marketplace this month. HealthEquity was selected as the 2020 ADP Marketplace Top Closer, for results from July 1, 2019 through June 30, 2020, and was also named an ADP Marketplace Platinum Partner.

HealthEquity named 2020 ADP Marketplace Top Closer, Platinum Partner

HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock?

Why Is HealthEquity (HQY) Down 11.5% Since Last Earnings Report?

HealthEquity: A Unique Long-Term Opportunity In A Thriving Segment

HealthEquity: Buy This Thriving Health Saving Account Administrator Despite The Challenging Low-Interest Environment

News for HealthEquity Stock (HQY)